Daniel Marsh

Daniel Marsh

Senior Markets Analyst

Daniel Marsh is a senior markets analyst at StockTi with over 12 years of experience covering U.S. and global equity markets. He holds a CFA charter and previously worked as an equity research associate at a major Wall Street firm. Daniel specializes in macroeconomic analysis, market trends, and cross-sector investment themes. His work focuses on translating complex market data into actionable insights for individual and institutional investors.

Markets, Economy, Analysis 4,258 articles

Articles by Daniel Marsh

Cash Yield Chasm: $4,500 Annual Gap on $100K
Markets

Cash Yield Chasm: $4,500 Annual Gap on $100K

Top savings accounts yield 5.00% APY versus the FDIC average of 0.38%, leaving $100,000 in idle cash $4,530 poorer annually. Banks like Green Dot (GDOT) and Axos Financial (AX) offer competitive rates but with caps.

GDOT AX NEWT
Rocket Lab Surges $8 Billion on Iridium Deal, Cash Flow Boost
Markets

Rocket Lab Surges $8 Billion on Iridium Deal, Cash Flow Boost

Rocket Lab shares surged 15.9% in premarket trading, adding $8.1 billion in market cap after announcing the acquisition of Iridium Communications for $8 billion.

RKLB IRDM QQQ DB WFC
Iridium Trades Above Rocket Lab Bid as Collar Narrows Spread
Markets

Iridium Trades Above Rocket Lab Bid as Collar Narrows Spread

Iridium shares trade $0.59 above Rocket Lab's $54 offer, signaling market confidence in the deal despite a long path to close.

IRDM RKLB QQQ IWM
AST SpaceMobile Soars $5.95B on Japan Satellite Subsidy Report
Markets

AST SpaceMobile Soars $5.95B on Japan Satellite Subsidy Report

AST SpaceMobile shares surged 21.44%, adding nearly $6 billion in market cap after reports of a $926 million Japanese government subsidy for a satellite project with Rakuten Group.

ASTS VZ T
Intel Stock Surges Past Analyst Targets Following Cantor Upgrade
Markets

Intel Stock Surges Past Analyst Targets Following Cantor Upgrade

Intel shares climbed 2.65% to $131.72, beating the Nasdaq, after Cantor raised its target to $150. The stock remains below its 52-week high amid cautious analyst ratings.

INTC NVDA AVGO MRVL AMD AAPL GOOGL
Super Micro Stock Drop Masks $39B AI Orders as Dilution Fears Mount
Markets

Super Micro Stock Drop Masks $39B AI Orders as Dilution Fears Mount

Super Micro Computer (SMCI) shares fell 8.1% Monday, even as the Nasdaq rose, as concerns over dilution and a Taiwan export probe offset $39 billion in AI server orders.

SMCI NVDA DELL SOXX
Comcast Shares Surge on Spin-Off Plan, Trade at 4.5x 2025 Free Cash Flow
Markets

Comcast Shares Surge on Spin-Off Plan, Trade at 4.5x 2025 Free Cash Flow

Comcast shares climbed 4.4% after announcing a tax-free spin-off of NBCUniversal and Sky. The stock now trades at 4.5x 2025 free cash flow, with Deutsche Bank upgrading to Buy.

CMCSA CHTR DIS NFLX SPY
American Airlines stock surpasses analyst target as jet fuel costs slide
Markets

American Airlines stock surpasses analyst target as jet fuel costs slide

American Airlines stock climbed to $17.92, exceeding its average analyst target, as falling jet fuel prices provide a tailwind. The airline's fuel sensitivity means every $1/gallon change impacts annual costs by $4.5 billion.

AAL DAL UAL LUV JBLU
Dow Ends at Record, Nasdaq Surges 2% as After-Hours ETFs Edge Lower
Markets

Dow Ends at Record, Nasdaq Surges 2% as After-Hours ETFs Edge Lower

The Dow closed at a record and the Nasdaq surged 2.07%, but major ETFs edged lower in after-hours trading as traders await June jobs data.

SPY QQQ DIA IWM NVDA MU AAPL MSFT AMZN GOOGL CMCSA VZ
Coeur Mining Rallies on Index Inclusion, Defies Silver Slump
Markets

Coeur Mining Rallies on Index Inclusion, Defies Silver Slump

Coeur Mining (CDE) rose 1.94% Monday, beating gold and silver ETFs, as its recent addition to the S&P MidCap 400 drew index-driven buying despite a drop in metals prices.

CDE GDX GLD SLV AG PAAS HL WPM NEM SPY
Abivax ADS Surges 29% on Obefazimod Safety Data, Paris Trading Expected to Catch Up
Markets

Abivax ADS Surges 29% on Obefazimod Safety Data, Paris Trading Expected to Catch Up

Abivax ADS surged nearly 30% after hours on positive safety data for obefazimod, adding $2.26B in market value. Paris shares are expected to open higher Wednesday.

SharonAI Shares Slip 1.28% After $1.6B Financing; Dilution Concerns Loom
Markets

SharonAI Shares Slip 1.28% After $1.6B Financing; Dilution Concerns Loom

SharonAI shares dropped 1.28% after closing a $1.6 billion financing that could dilute existing shareholders by 79%. Funds will back a six-year compute deal with NVIDIA.

NVDA